554 related articles for article (PubMed ID: 9328442)
21. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
Bhasin G; Kauser H; Athar M
Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
[TBL] [Abstract][Full Text] [Related]
22. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
23. The chlorinated pesticide mirex is a novel nonphorbol ester-type tumor promoter in mouse skin.
Moser GJ; Meyer SA; Smart RC
Cancer Res; 1992 Feb; 52(3):631-6. PubMed ID: 1732051
[TBL] [Abstract][Full Text] [Related]
24. Non-melanoma skin cancer in mouse and man.
Schwarz M; Münzel PA; Braeuning A
Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
[TBL] [Abstract][Full Text] [Related]
25. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
26. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
[TBL] [Abstract][Full Text] [Related]
27. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
28. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
29. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
Trempus CS; Haseman JK; Tennant RW
Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
31. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
32. Influence of diet restriction and tumor promoter dose on cell proliferation, oxidative DNA damage and rate of papilloma appearance in the mouse skin after initiation with DMBA and promotion with TPA.
Fischer WH; Lutz WK
Toxicol Lett; 1998 Sep; 98(1-2):59-69. PubMed ID: 9776562
[TBL] [Abstract][Full Text] [Related]
33. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
[TBL] [Abstract][Full Text] [Related]
34. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
Yokota K; Gill TJ; Shinozuka H
Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
36. Tumor progression of murine epidermal cells after treatment in vitro with 12-O-tetradecanoylphorbol-13-acetate or retinoic acid.
Kulesz-Martin MF; Blumenson LE; Manly KF; Siracký J; East CJ
Cancer Res; 1991 Sep; 51(17):4701-6. PubMed ID: 1908351
[TBL] [Abstract][Full Text] [Related]
37. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
[TBL] [Abstract][Full Text] [Related]
38. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
39. Characterization of mutant HA-ras gene expression in transformed murine keratinocyte lines grown under in vitro and in vivo conditions.
Volpe JP; Conti CJ; Slaga TJ
Mol Carcinog; 1996 Dec; 17(4):202-6. PubMed ID: 8989913
[TBL] [Abstract][Full Text] [Related]
40. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.
Dlugosz AA; Hansen L; Cheng C; Alexander N; Denning MF; Threadgill DW; Magnuson T; Coffey RJ; Yuspa SH
Cancer Res; 1997 Aug; 57(15):3180-8. PubMed ID: 9242447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
